Global Personalized Genomics Market Overview:
Global Personalized Genomics Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Personalized Genomics Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Personalized Genomics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Personalized Genomics Market:
The Personalized Genomics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Personalized Genomics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Personalized Genomics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Personalized Genomics market has been segmented into:
Oncology Testing
Infectious Disease Testing
Neurological Testing
Cardiovascular Testing
Others
By Application, Personalized Genomics market has been segmented into:
PCR-based Tests
Microarray-based Tests
Sequencing-based Tests
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Personalized Genomics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Personalized Genomics market.
Top Key Players Covered in Personalized Genomics market are:
23andMe
Mapmygenome
Invitea
Genetic Technology Limited
Lonza
Interleukin Geneticsinc
GNA Genotek
Helix
MyHeritage
Pathway Genomics
Veritas Genetics
Xcode
Color Genomics
Myriad Genetics
Quest Diagnostics
Bio-Rad Laboratoriesinc.
Illumina
Thermo Fisher Scientific
Qiagen
Genomic Health
Nebula Genomics
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Personalized Genomics Market by Type
4.1 Personalized Genomics Market Snapshot and Growth Engine
4.2 Personalized Genomics Market Overview
4.3 Oncology Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Oncology Testing: Geographic Segmentation Analysis
4.4 Infectious Disease Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Infectious Disease Testing: Geographic Segmentation Analysis
4.5 Neurological Testing
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Neurological Testing: Geographic Segmentation Analysis
4.6 Cardiovascular Testing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Cardiovascular Testing: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Others: Geographic Segmentation Analysis
Chapter 5: Personalized Genomics Market by Application
5.1 Personalized Genomics Market Snapshot and Growth Engine
5.2 Personalized Genomics Market Overview
5.3 PCR-based Tests
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 PCR-based Tests: Geographic Segmentation Analysis
5.4 Microarray-based Tests
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Microarray-based Tests: Geographic Segmentation Analysis
5.5 Sequencing-based Tests
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Sequencing-based Tests: Geographic Segmentation Analysis
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Personalized Genomics Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 23ANDME
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 MAPMYGENOME
6.4 INVITEA
6.5 GENETIC TECHNOLOGY LIMITED
6.6 LONZA
6.7 INTERLEUKIN GENETICSINC
6.8 GNA GENOTEK
6.9 HELIX
6.10 MYHERITAGE
6.11 PATHWAY GENOMICS
6.12 VERITAS GENETICS
6.13 XCODE
6.14 COLOR GENOMICS
6.15 MYRIAD GENETICS
6.16 QUEST DIAGNOSTICS
6.17 BIO-RAD LABORATORIESINC.
6.18 ILLUMINA
6.19 THERMO FISHER SCIENTIFIC
6.20 QIAGEN
6.21 GENOMIC HEALTH
6.22 NEBULA GENOMICS
Chapter 7: Global Personalized Genomics Market By Region
7.1 Overview
7.2. North America Personalized Genomics Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Oncology Testing
7.2.4.2 Infectious Disease Testing
7.2.4.3 Neurological Testing
7.2.4.4 Cardiovascular Testing
7.2.4.5 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 PCR-based Tests
7.2.5.2 Microarray-based Tests
7.2.5.3 Sequencing-based Tests
7.2.5.4 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Personalized Genomics Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Oncology Testing
7.3.4.2 Infectious Disease Testing
7.3.4.3 Neurological Testing
7.3.4.4 Cardiovascular Testing
7.3.4.5 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 PCR-based Tests
7.3.5.2 Microarray-based Tests
7.3.5.3 Sequencing-based Tests
7.3.5.4 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Personalized Genomics Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Oncology Testing
7.4.4.2 Infectious Disease Testing
7.4.4.3 Neurological Testing
7.4.4.4 Cardiovascular Testing
7.4.4.5 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 PCR-based Tests
7.4.5.2 Microarray-based Tests
7.4.5.3 Sequencing-based Tests
7.4.5.4 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Personalized Genomics Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Oncology Testing
7.5.4.2 Infectious Disease Testing
7.5.4.3 Neurological Testing
7.5.4.4 Cardiovascular Testing
7.5.4.5 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 PCR-based Tests
7.5.5.2 Microarray-based Tests
7.5.5.3 Sequencing-based Tests
7.5.5.4 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Personalized Genomics Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Oncology Testing
7.6.4.2 Infectious Disease Testing
7.6.4.3 Neurological Testing
7.6.4.4 Cardiovascular Testing
7.6.4.5 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 PCR-based Tests
7.6.5.2 Microarray-based Tests
7.6.5.3 Sequencing-based Tests
7.6.5.4 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Personalized Genomics Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Oncology Testing
7.7.4.2 Infectious Disease Testing
7.7.4.3 Neurological Testing
7.7.4.4 Cardiovascular Testing
7.7.4.5 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 PCR-based Tests
7.7.5.2 Microarray-based Tests
7.7.5.3 Sequencing-based Tests
7.7.5.4 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Personalized Genomics Scope:
|
Report Data
|
Personalized Genomics Market
|
|
Personalized Genomics Market Size in 2025
|
USD XX million
|
|
Personalized Genomics CAGR 2025 - 2032
|
XX%
|
|
Personalized Genomics Base Year
|
2024
|
|
Personalized Genomics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
23andMe, Mapmygenome, Invitea, Genetic Technology Limited, Lonza, Interleukin Geneticsinc, GNA Genotek, Helix, MyHeritage, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Myriad Genetics, Quest Diagnostics, Bio-Rad Laboratoriesinc., Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health, Nebula Genomics.
|
|
Key Segments
|
By Type
Oncology Testing
Infectious Disease Testing
Neurological Testing
Cardiovascular Testing
Others
By Applications
PCR-based Tests
Microarray-based Tests
Sequencing-based Tests
Others
|
